Active	Status	Sponsor type	Region	Phase	Filter
7 Active 5 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Beitelshees, Amber L
PRS, NCT06813014: Pharmacogenetics of Response to Sitagliptin	Not yet recruiting	4	400	US	Oral Glucose Tolerance Test	University of Maryland, Baltimore	Diabetes	05/30	05/31
PORT, NCT05071898: Pharmacogenetics of Response to GLP1R Agonists	Recruiting	1	600	US	Semaglutide Pen Injector [Ozempic], Ozempic, Wegovy	University of Maryland, Baltimore	Obesity, Diabetes Type 2	11/26	12/27
Taylor, Simeon I
PRS, NCT06813014: Pharmacogenetics of Response to Sitagliptin	Not yet recruiting	4	400	US	Oral Glucose Tolerance Test	University of Maryland, Baltimore	Diabetes	05/30	05/31
NCT05762744: Pharmacogenomics of GLP1 Receptor Agonists	Terminated	1	78	US	Exenatide Injection, BYETTA, Saline injection	University of Maryland, Baltimore	Type 2 Diabetes	11/18	10/22
NCT02891954: Genetics of Response to Canagliflozin	Active, not recruiting	1	700	NA	Canagliflozin, Invokana (brand name for canagliflozin)	University of Maryland, Baltimore, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Diabetes Mellitus, Type 2	09/23	09/25
Shaub, Susan
PORT, NCT05071898: Pharmacogenetics of Response to GLP1R Agonists	Recruiting	1	600	US	Semaglutide Pen Injector [Ozempic], Ozempic, Wegovy	University of Maryland, Baltimore	Obesity, Diabetes Type 2	11/26	12/27
NCT05348564: Comparing Direct vs Indirect Methods for Cascade Screening	Recruiting	N/A	200	US	Direct contact of family members for cascade screening of relevant variants	University of Maryland, Baltimore	Long QT Syndrome, Familial Hypercholesterolemia, Ethics, Genetic Testing	03/26	03/27